References

NAG kit

Price RG (1992)

The role of NAG (N-acetyl-b-D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. Clin. Nephrol. 38, Suppl. 1 (pp. S14-S19).

Price RG (1992)

Measurement of N-acetyl-b-D-Glucosaminidase and its IsoEnzymes in Urine Methods and Applications. Eur. J. Clin. Biochem. 30,693-705.

Price RG (1991)

New colorimetric substrates for the assay of hydrolytic enzymes: N-acetyl-b -D-Glucosaminidase (NAG) Chimica Oggi 6, 15-19.

Mueller PW, Price RG and Porter GA (1997)

Proceedings of the joint EU/US Workshop. Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins. Renal Failure 19, 501-505.

Dewji NN, De Keyser DR and Stirling JL (1986)

Purification and characterization of b -N-acetylhexosaminidase I2 form from human liver. Biochem. J. 234, 157-162.

Robinson D and Stirling JL (1968)

N-Acetyl-b -D-glucosaminidase in human Spleen. Biochem J. 107, 321-327.

Swallow DM, Stokes DC, Corney C and Harris H (1974)

Differences between the N-acetyl Hexosaminidase isoenzymes in serum and tissues. Ann. Hum. Genet. London 37, 287-302.

Microbiology

Khan et al., 2000, Abstract

13th International Organisation for Mycoplasmology, Japan, pp260

Cooke VM, Miles RJ, Price RG, Midgley G, Khamri W, Richardson AC (2002)

New chromogenic agar medium for the identification of Candida spp. Appl. Environ. Microbiol. 68:3622-7.

Cooke VM, Miles RJ, Price RG, Richardson AC. (1999)

A novel chromogenic ester agar medium for the detection of salmonellae. Appl. Environ. Microbiol. 65:807-12.

Bainbridge B W, Mathias N, Price R G, Richardson A C, Sandhu J and Smith B V (1991)

Improved method for the detection of B-galactosidase activity
in colonies of Escherichia coli using a new chromogenic substrate. FEMS Microbiological Lett. 80, 319-324.

Paffard S M, Miles R J, Clark C R and Price R G (1997)

Amplified Enzyme-Linked-Immunofilter Assays enable detection of 50-105 Bacterial Cells within 1 Hour. Analytical biochemistry 248, 265-268.

Miles R J, Siu E L T, Carrington C, Richardson A C, Smith B V and Price R G (1992)

The detection of lipase activity in bacteria using novel substrates. FEMS Microbiological Lett. 90, 283-288

Sanchez-Bernal, C., Robinson G, Miles R J and Price R G (1994)

Development of a Sensitive and quantitative enzyme linked immunofilter assay (ELIFA) for whole bacterial cells. J. Microbiol. Methods 19, 135-143.

Paffard, S M, Miles R. J., Clark C R and Price R G (1996)

A sensitive forty-minute enzyme linked immunofilter assay (ELIFA) for whole bacterial cells. J. Immunol. Methods. 192, 133-136.

Substrates

Yuen et al., Ann. Clin. Biochem., 1984, 21, 295 300

A substrate for ß galactosidases

Pócsi et al., Biochim. Biophys. Acta, 1993, 1163, 54-60

Comparison of several new chromogenic galactosides as substrates for various ß-D-galactosidases

Pócsi et al., Clin. Chem., 1990, 36, 1884

Exemplary substrate of urinary N acetylglucosaminidase

Yuen et al., Clin. Chim. Acta, 1991, 112, 99.

Substrate for esterases

Miles et al., FEMS Micro Lett., 1992, 90, 283

Substrate for the assay of esterases

Richardson A C, Smith B V, Praill P F G and Price R G (1988)

Reagent and kit for enzyme assay comprising a substrate consonant with given enzyme to be assayed. US Patent 5, 221, 606.

Diphencyprone

Higgins E and du Vivier A (2002)

Topical immunotherapy: Unapproved uses, dosages or indications. Clinics in dermatology 20:515-521.

Buckley DA, Keane FM, Munn SE, Fuller LC, Higgins EM and du Vivier AWP (1999)

Recalcitrant warts treated by diphencyprone immunotherapy. British Journal of Dermatology 141:292-296.

Happle R (2002)

Diphencyprone for the treatment of Alopaecia areata, more data and new aspects [Editorial]. Arch Dermatol 138:1123-113.